Clinical Trials Browser

7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole × 1 year × Clear all

NCT06723015 2025-11-18

Tau PET Outcomes With Anti-amyloid Immunotherapies

Phase 2 Enrolling by invitation

Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction